跳至主要内容
临床试验/CTRI/2017/12/010770
CTRI/2017/12/010770已完成3 期

Treatment of tinea with terbinafine and fluconazole

Institute of Medical Sciences0 个研究点目标入组 117 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
117

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Tinea corporis/cruris/faciei
  • 2. Positive KOH microscopy for fungus
  • 3. Patient not on terbinafine or fluconazole
  • 4. Patient on itraconazole but unsatisfied with treatment
  • Criteria 1 to 3 mandatory, criteria 4 applies if patient on itraconazole

排除标准

  • 1. Pregnancy
  • 2. Lactation
  • 3. Inability to come for follow up
  • 4. History of adverse reaction to terbinafine or fluconazole
  • 5. Current treatment with drugs with potential of interaction with terbinafine or fluconazole
  • 6. Renal or liver or cardiac disease or history of chest pain
  • 7. Abnormalities in CBC, LFT, RFT
  • (for hemoglobin <9gm/dl, platelet count <1 lac/per microliter, SGOT and SGPT >100 units per liter considered exclusion criteria)

研究者

发起方
Institute of Medical Sciences

相似试验